Liposomal Irinotecan Plus Fluorouracil/leucovorin Versus FOLFIRINOX As the Second-Line Chemotherapy for Patients with Metastatic Pancreatic Cancer: a Multicenter Retrospective Study of the Korean Cancer Study Group (KCSG)

H. S. Park,B. Kang,H. J. Chon,H-S Im,C-K Lee,I Kim,M. J. Kang,J. E. Hwang,W. K. Bae,J. Cheon,J. O. Park,J. Y. Hong,J. H. Kang,J. H. Kim,S. H. Lim,J. W. Kim,J-W Kim,C. Yoo,H. J. Choi

Journal of Clinical Oncology（2020）

引用 23|浏览33

暂无评分

关键词

pancreatic cancer,second-line treatment,liposomal irinotecan,FOLFIRINOX

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要